Alteration of AP-1 activity varies according to the pathogen, for instance it has been shown, that the hepatitis C virus alters MAP kinases and AP-1 to accelerate the cell cycle progression, helping the development of hepatocellular carcinoma and HCV development [42]. This evidence concerns the gene FOS and hepatocellular carcinoma.